This inventor holds 4 USPTO granted patents. Top assignee: Hoechst Aktiengesellschaft. Active years: 1976-1980.
Company Filing History:
Years Active: 1976-1980
Title: Ernst Lindner: Innovator in Pharmaceutical Chemistry
Introduction
Ernst Lindner is a notable inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of 4 patents to his name, Lindner's work has had a meaningful impact on medical science.
Latest Patents
Lindner's latest patents include innovative compounds such as 1-Aryloxy-2-hydroxy-3-aminopropanes. These compounds are characterized by a complex formula that allows for various substitutions, making them versatile in application. Additionally, he has developed novel peptide derivatives that exhibit antihypertensive effects, providing new avenues for the diagnosis and treatment of hypertension.
Career Highlights
Throughout his career, Lindner has been associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work has focused on creating compounds that not only advance scientific understanding but also offer practical solutions to health issues.
Collaborations
Lindner has collaborated with esteemed colleagues such as Werner Fritsch and Ulrich Stache. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.
Conclusion
Ernst Lindner's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of therapeutic compounds that address critical health challenges.